In a report published Friday, Morgan Stanley analyst Christopher Caponetti upgraded the rating on Endo International PLC ENDP from Equal-Weight to Overweight, and named a $79.00 price target.
In the report, Morgan Stanley noted, “Mesh settlement removes what had been a potential multi-billion dollar liability in our bear case, and we now see a compelling risk-reward driven by M&A upside in our bull case. Our $79 PT assumes mgmt. follows through on 2-3 deals over the near-term.”
Endo International PLC closed on Thursday at $66.36.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in